A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Dacarbazine Related Compound B | Dacarbazine Related Compound B. Uses: For analytical and research use. CAS No. 4656-86-4 (anhydrous). Mole weight: 155.11. Catalog: ALP4656864. |  |
| Dacarbazine USP Related Compound B | An impurity of Dacarbazine, which is used as an antineoplastic for treatment of various cancers such as, malignant melanoma and sarcomas. Synonyms: Dacarbazine Impurity A monohydrate; Dacarbazine EP Impurity A monohydrate; Dacarbazine Related Compound B; USP Dacarbazine Related Compound B; 4H-Imidazo[4,5-d]-1,2,3-triazin-4-one, 3,7-dihydro-, hydrate (1:1); 7H-Imidazo[4,5-d]-1,2,3-triazin-4-ol, monohydrate; 3,7-Dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one monohydrate; 1,5-Dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one monohydrate; 2-Azahypoxanthine monohydrate; Azahypoxanthine monohydrate; NSC 22419 monohydrate. Grade: ≥95%. CAS No. 7151-3-3. Molecular formula: C4H5N5O2. Mole weight: 155.12. |  |
| Dacetuzumab | Dacetuzumab is an anti-CD40 monoclonal antibody that has been developed for the treatment of relapsed diffuse large B-cell lymphoma (DLBCL). Synonyms: SGN-40; SGN 40; SGN40; huS2C6. CAS No. 880486-59-9. | |
| Dacetuzumab | Dacetuzumab (SGN-40) is a humanized IgG1, anti-CD40 monoclonal antibody with anti-lymphoma activity. Dacetuzumab kills tumor cells via immune effector functions (antibody-dependent cellular cytotoxicity and phagocytosis [ADCC/ADCP]). Dacetuzumab ((SGN-40) can be used for multiple myeloma research[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 880486-59-9. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99015. |  |
| Dacinostat | Dacinostat is a potent HDAC inhibitor, with an IC50 of 32 nM; Dacinostat also inhibits HDAC1 with an IC50 of 9 nM, and used in cancer research. Uses: Scientific research. Category: Signaling pathways. Alternative Names: NVP-LAQ824; LAQ824. CAS No. 404951-53-7. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 500 mg; 1 g. Product ID: HY-13606. | |
| Dacinostat | Dacinostat, also known as LAQ824, is a hydroxamate histone deacetylase inhibitor with potential anticancer activity. LAQ824 sensitized nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation. LAQ824 reduced clonogenic survival of the H23 and H460 cell lines five-fold compared with controls and four-fold compared with either agent alone (P<0.001). In phase I trials, LAQ824 was well tolerated at doses that induced accumulation of histone acetylation, with higher doses inducing changes consistent with HSP90 inhibition. Synonyms: NVP-LAQ824; NVP LAQ824; LAQ-824; LAQ824; LAQ 824; Dacinostat. CAS No. 404951-53-7. Molecular formula: C22H25N3O3. Mole weight: 379.46. | |
| Daclatasvir | Daclatasvir, inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: Daclatasvir; BMS-790052; BMS 790052; BMS790052; EBP-883; EBP 883; EBP883; trade name Daklinza. Grade: 0.98. CAS No. 1009119-64-5. Molecular formula: C40H50N8O6. Mole weight: 738.89. | |
| Daclatasvir | Daclatasvir. Group: Biochemicals. Grades: Highly Purified. CAS No. 1009119-64-5. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. US Biological Life Sciences. |  Worldwide |
| Daclatasvir | Daclatasvir (BMS-790052) is a potent and orally active HCV NS5A protein inhibitor with EC50s range of 9-146 pM for multiple HCV replicon genotypes. Daclatasvir is also a organic anion transporting polypeptide 1B (OATP1B) and OATP1B3 inhibitor with IC50s of 1.5 μM and 3.27 μM, respectively[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BMS-790052; EBP 883. CAS No. 1009119-64-5. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 200 mg. Product ID: HY-10466. | |
| Daclatasvir-d16 | Daclatasvir-d16 is a labelled Daclatasvir which inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: BMS-790052-d16; EBP 883-d16. Grade: > 95%. Molecular formula: C40H34D16N8O6. Mole weight: 754.97. | |
| Daclatasvir-d6 | Daclatasvir-[d6], is the labelled analogue of Daclatasvir. Daclatasvir, inhibits the HCV protein NS5A, and can be used in combination with other medications to treat hepatitis C (HCV). Synonyms: 1801709-41-0; Daclatasvir-d6; Melphalan Dimer-d8 Dihydrochloride; MelphalanDimer-d8Dihydrochloride; trideuteriomethyl N-[(2S)-3-methyl-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-3-methyl-2-(trideuteriomethoxycarbonylamino)butanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamate; Daclatasvir SRRS Isomer-d6; DA-62636. Grade: > 95%. CAS No. 1801709-41-0. Molecular formula: C40H44D6N8O6. Mole weight: 744.91. | |
| Daclatasvir Diethyl Ester-d10 | Daclatasvir Diethyl Ester-d10 is the isotope labelled analog of Daclatasvir Diethyl Ester (D101525); an impurity of Daclatasvir (D101500) which is a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg, 5mg. Molecular Formula: C42H44D10N8O6, Molecular Weight: 776.99. US Biological Life Sciences. | Worldwide |
| Daclatasvir dihydrochloride | Daclatasvir is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture. Synonyms: Methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate dihydrochloride; Daclatasvir; BMS790052; BMS 790052; BMS-790052; EBP883; EBP 883; EBP-883; Daklinza. Grade: >98%. CAS No. 1009119-65-6. Molecular formula: C40H50N8O6ยท2HCl. Mole weight: 811.8. | |
| Daclatasvir Impurity 1 | Daclatasvir Impurity 1. Uses: For analytical and research use. CAS No. 2698401-11-3. Molecular formula: C40H51ClN8O6. Mole weight: 775.35. Catalog: APB2698401113. | |
| Daclatasvir Impurity 10 | Daclatasvir Impurity 10. Uses: For analytical and research use. CAS No. 1009119-83-8. Molecular formula: C26H29ClN6. Mole weight: 461.01. Catalog: APB1009119838. | |
| Daclatasvir Impurity 11 | Daclatasvir Impurity 11. Uses: For analytical and research use. CAS No. 1007882-23-6. Molecular formula: C36H44N6O4. Mole weight: 624.79. Catalog: APB1007882236. | |
| Daclatasvir Impurity 1 (RSSS-Isomer) | Daclatasvir Impurity 1 (RSSS-Isomer). Uses: For analytical and research use. Alternative Names: dimethyl ((2S,2'R)-((2S,2'S)-2,2'-(5,5'-([1,1'-biphenyl]-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl))dicarbamate. CAS No. 1417333-83-5. Molecular formula: C40H50N8O6. Mole weight: 738.88. Catalog: APB1417333835. | |
| Daclatasvir Impurity 1 (SRSS-Isomer) | Daclatasvir Impurity 1 (SRSS-Isomer). Uses: For analytical and research use. Alternative Names: Daclatasvir Impurity 1 (SRSS-Isomer). CAS No. 1009117-28-5. Molecular formula: C40H50N8O6. Mole weight: 738.88. Catalog: APB1009117285. | |
| Daclatasvir Impurity 3 | Daclatasvir Impurity 3. Uses: For analytical and research use. CAS No. 2226822-77-9. Molecular formula: C40H51ClN8O6. Mole weight: 775.35. Catalog: APB2226822779. | |
| Daclatasvir Impurity 4 | Daclatasvir Impurity 4. Uses: For analytical and research use. CAS No. 1009117-26-3. Molecular formula: C40H50N8O6. Mole weight: 738.89. Catalog: APB1009117263. | |
| Daclatasvir Impurity 5 | Daclatasvir Impurity 5. Uses: For analytical and research use. CAS No. 1009107-27-0. Molecular formula: C40H50N8O6. Mole weight: 738.89. Catalog: APB1009107270. | |
| Daclatasvir Impurity 6 | Daclatasvir SRRS Isomer is an isomer of Daclatasvir, a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: Daclatasvir SRRS Isomer; N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2R)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic Acid C,C'-Dimethyl Ester. Grade: > 95%. CAS No. 1009117-26-3. Molecular formula: C40H50N8O6. Mole weight: 738.88. | |
| Daclatasvir Impurity 6 | Daclatasvir Impurity 6. Uses: For analytical and research use. CAS No. 2077207-88-4. Molecular formula: C41H52N8O6. Mole weight: 752.92. Catalog: APB2077207884. | |
| Daclatasvir Impurity 7 | Daclatasvir Impurity 7. Uses: For analytical and research use. Molecular formula: C40H49N7O7. Mole weight: 739.87. Catalog: APB12391. | |
| Daclatasvir Impurity 8 | Daclatasvir Impurity 8. Uses: For analytical and research use. CAS No. 2226541-13-3. Molecular formula: C35H41N7O4. Mole weight: 623.76. Catalog: APB2226541133. | |
| Daclatasvir Impurity 9 | Daclatasvir Impurity 9. Uses: For analytical and research use. CAS No. 1007884-60-7. Molecular formula: C33H39N7O3. Mole weight: 581.72. Catalog: APB1007884607. | |
| Daclatasvir RSSR Isomer | Daclatasvir RSSR Isomer is an isomer of Daclatasvir, a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: Daclatasvir Impurity 4; N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1R)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic Acid C,C'-Dimethyl Ester. Grade: > 95%. CAS No. 1009107-27-0. Molecular formula: C40H50N8O6. Mole weight: 738.88. | |
| Daclatasvir RSSS Isomer | Daclatasvir RSSS Isomer is an isomer of Daclatasvir, a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-2,1-pyrrolidinediyl[1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid C,C'-dimethyl ester stereoisomer. CAS No. 1417333-83-5. Molecular formula: C40H50N8O6. Mole weight: 738.88. | |
| Daclizumab | Daclizumab is a humanized monoclonal antibody of the human IgG1 isotype that binds specifically to the Tac epitope on the α-subunit (CD25) of the IL-2R. Synonyms: Zenapax; Ro 24-7375. CAS No. 152923-56-3. Molecular formula: C6332H9808N1678O1989S42. Mole weight: 142612.1. | |
| Daclizumab | Daclizumab (Ro 24-7375) is a humanized, monoclonal antibody that blocks CD25 (α-subunit of the high-affinity interleukin-2 receptor (IL-2R-HA)). Daclizumab inhibits effector T cell activation, regulatory T cell (Treg) expansion and survival, and activation-induced T-cell apoptosis. Daclizumab increases IL-2 bioavailability to bind to the intermediate-affinity IL-2R (IL-2R-IA), driving the expansion of anti-inflammatory CD56bright natural killer (NK) cells. Daclizumab can be used for multiple sclerosis and cancer research[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Ro 24-7375. CAS No. 152923-56-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-108738. | |
| DACM | DACM (N-(7-Dimethylamino-4-methyl-3-coumarinyl)maleimide) is a thiol-directed fluorescent dye (Ex=396 nm, Em=468 nm)[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: N-(7-Dimethylamino-4-methyl-3-coumarinyl)maleimide. CAS No. 55145-14-7. Pack Sizes: 1 mg. Product ID: HY-121030. | |
| Dacomitinib | Dacomitinib, aslo known as PF-299 and PF-00299804; or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Dacomitinib specifically and irreversibly binds to and inhibits human EGFR subtypes, resulting in inhibition of proliferation and induction of apoptosis in EGFR-expressing tumor cells. EGFRs play major roles in tumor cell proliferation and tumor vascularization, and are often overexpressed or mutated in various tumor cell types. Synonyms: dacomitinib; PF-00299804; PF00299804; PF 00299804; PF299804; PF-299804; PF 299804; PF-299; PF 299; PF299. CAS No. 1110813-31-4. Molecular formula: C24H25ClFN5O2. Mole weight: 469.945. | |
| Dacomitinib | Dacomitinib (PF-00299804) is a specific and irreversible inhibitor of the ERBB family of kinases with IC50s of 6 nM, 45.7 nM and 73.7 nM for EGFR, ERBB2, and ERBB4, respectively[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: PF-00299804; PF-299804. CAS No. 1110813-31-4. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg. Product ID: HY-13272. | |
| Dacomitinib | Dacomitinib (PF299)(PF299804; PF-00299804) is a highly selective, orally bioavailable small-molecule inhibitor of the HER family of tyrosine kinases with IC50 of 6, 45.7 and 73.7 nM for EGFR, ERBB2, and ERBB4, respectively. Category: Active pharmaceutical ingredients. Synonyms: PF-299804, PF-00299804, PF299. Grades: DMF. CAS No. 1110813-31-4. Product ID: API1110813314. Molecular formula: C24H25ClFN5O2. Mole weight: 469.94. Standard: Facility GMP. |  |
| Dacomitinib hydrate | Dacomitinib hydrate (PF 299804) is a highly selective and second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor family of tyrosine kinases. Category: Active pharmaceutical ingredients. Synonyms: PF 299804. CAS No. 1042385-75-0. Product ID: API1042385750. Molecular formula: C24H27ClFN5O3. Mole weight: 487.96. | |
| Dacomitinib Hydrate | Dacomitinib is a second-generation small molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) tyrosine kinase family (ErbB family) with potential anti-tumor activity. Uses: Tyrosine kinase inhibitors. Synonyms: PF-00299804; PF00299804; PF 00299804; PF299804. CAS No. 1042385-75-0. Molecular formula: C24H25ClFN5O2.H2O. Mole weight: 487.96. | |
| Dacomitinib Impurity 1 | Dacomitinib Impurity 1. Uses: For analytical and research use. Molecular formula: C8H3FN4O5. Mole weight: 254.13. Catalog: APB12399. | |
| Dacomitinib Impurity 10 | Dacomitinib Impurity 10. Uses: For analytical and research use. Alternative Names: (E)-N-(4-((3,4-difluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular formula: C24H25F2N5O2. Mole weight: 453.48. Catalog: APB05285. | |
| Dacomitinib Impurity 10 | Dacomitinib Impurity 10. Uses: For analytical and research use. CAS No. 2106-05-0. Molecular formula: C6H5ClFN. Mole weight: 145.56. Catalog: APB2106050. | |
| Dacomitinib Impurity 11 | Dacomitinib Impurity 11. Uses: For analytical and research use. Alternative Names: (E)-N-(4-((4-chloro-3-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular formula: C24H25ClFN5O2. Mole weight: 469.94. Catalog: APB05284. | |
| Dacomitinib Impurity 11 | Dacomitinib Impurity 11. Uses: For analytical and research use. CAS No. 13991-36-1. Molecular formula: C4H5BrO2. Mole weight: 164.99. Catalog: APB13991361. | |
| Dacomitinib Impurity 12 | Dacomitinib Impurity 12. Uses: For analytical and research use. Alternative Names: (E)-N-(4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular formula: C24H25ClFN5O2. Mole weight: 469.94. Catalog: APB05283. | |
| Dacomitinib Impurity 13 | Dacomitinib Impurity 13. Uses: For analytical and research use. Alternative Names: (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-fluoroquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular formula: C23H22ClF2N5O. Mole weight: 457.9. Catalog: APB05281. | |
| Dacomitinib Impurity 14 | Dacomitinib Impurity 14. Uses: For analytical and research use. Molecular formula: C26H32ClFN6O2. Mole weight: 515.03. Catalog: APB12400. | |
| Dacomitinib Impurity 15 | Dacomitinib Impurity 15. Uses: For analytical and research use. Alternative Names: (E)-N-(5-cyano-4-((E)-((dimethylamino)methylene)amino)-2-methoxyphenyl)-4-(piperidin-1-yl)but-2-enamide. Molecular formula: C20H27N5O2. Mole weight: 369.46. Catalog: APB05282. | |
| Dacomitinib Impurity 16 | Dacomitinib Impurity 16. Uses: For analytical and research use. Alternative Names: (E)-N-(4-((4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular formula: C24H26FN5O2. Mole weight: 435.49. Catalog: APB05280. | |
| Dacomitinib Impurity 17 | Dacomitinib Impurity 17. Uses: For analytical and research use. Alternative Names: (E)-N-(4-((3-chlorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular formula: C24H26ClN5O2. Mole weight: 451.95. Catalog: APB05279. | |
| Dacomitinib Impurity 2 | Dacomitinib Impurity 2. Uses: For analytical and research use. Molecular formula: C8H4N4O6. Mole weight: 252.14. Catalog: APB12398. | |
| Dacomitinib Impurity 2 | Dacomitinib Impurity 2. Uses: For analytical and research use. Alternative Names: 2-chloro-1-fluoro-4-nitrobenzene. CAS No. 350-30-1. Molecular formula: C6H3ClFNO2. Mole weight: 175.54. Catalog: APB350301. | |
| Dacomitinib Impurity 2F3L | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C24H25ClFN5O2. Mole weight: 469.95. | |
| Dacomitinib Impurity 3 | Dacomitinib Impurity 3. Uses: For analytical and research use. CAS No. 2250242-14-7. Molecular formula: C8H4N4O6. Mole weight: 252.14. Catalog: APB2250242147. | |
| Dacomitinib Impurity 3F4L | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C24H25ClFN5O2. Mole weight: 469.95. | |
| Dacomitinib Impurity 3F4LAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C15H12ClFN4O. Mole weight: 318.73. | |
| Dacomitinib Impurity 3F4LXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C15H10ClFN4O3. Mole weight: 348.72. | |
| Dacomitinib Impurity 4 | Dacomitinib Impurity 4. Uses: For analytical and research use. Alternative Names: 1-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-5-(piperidin-1-yl)pyrrolidin-2-one. Molecular formula: C24H25ClFN5O2. Mole weight: 469.94. Catalog: APB05290. | |
| Dacomitinib Impurity 5 | Dacomitinib Impurity 5. Uses: For analytical and research use. Alternative Names: 1-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-5-hydroxypyrrolidin-2-one. CAS No. 2190490-31-2. Molecular formula: C19H16ClFN4O3. Mole weight: 402.81. Catalog: APB2190490312. | |
| Dacomitinib Impurity 5 | Dacomitinib Impurity 5. Uses: For analytical and research use. CAS No. 53449-14-2. Molecular formula: C8H4ClN3O3. Mole weight: 225.59. Catalog: APB53449142. | |
| Dacomitinib Impurity 6 | Dacomitinib Impurity 6. Uses: For analytical and research use. Alternative Names: 5-((3-chloro-4-fluorophenyl)amino)-1-(4-((3-chlorophenyl)amino)-7-methoxyquinazolin-6-yl)pyrrolidin-2-one. Molecular formula: C25H20Cl2FN5O2. Mole weight: 512.36. Catalog: APB05288. | |
| Dacomitinib Impurity 7 | Dacomitinib Impurity 7. Uses: For analytical and research use. Alternative Names: (E)-N-(3-(3-chloro-4-fluorophenyl)-4-imino-7-methoxy-3,4-dihydroquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular formula: C24H25ClFN5O2. Mole weight: 469.94. Catalog: APB05289. | |
| Dacomitinib Impurity 7 | Dacomitinib Impurity 7. Uses: For analytical and research use. CAS No. 2168856-93-5. Molecular formula: C7H5FN2O4. Mole weight: 200.13. Catalog: APB2168856935. | |
| Dacomitinib Impurity 8 | Dacomitinib Impurity 8. Uses: For analytical and research use. Alternative Names: (E)-N-(4-(N-(3-chloro-4-fluorophenyl)acetamido)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular formula: C26H27ClFN5O3. Mole weight: 511.98. Catalog: APB05286. | |
| Dacomitinib Impurity 9 | Dacomitinib Impurity 9. Uses: For analytical and research use. Alternative Names: (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)but-2-enamide. Molecular formula: C19H16ClFN4O2. Mole weight: 386.81. Catalog: APB05287. | |
| Dacomitinib Impurity 9 | Dacomitinib Impurity 9. Uses: For analytical and research use. CAS No. 119023-25-5. Molecular formula: C7H7FN2O. Mole weight: 154.14. Catalog: APB119023255. | |
| Dacomitinib Impurity BDS | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C19H16ClFN4O2. Mole weight: 386.81. | |
| Dacomitinib Impurity C | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. CAS No. 869199-69-9. Molecular formula: C25H27ClFN5O2. Mole weight: 483.97. | |
| Dacomitinib Impurity D | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. CAS No. 869199-67-7. Molecular formula: C26H29ClFN5O2. Mole weight: 497.99. | |
| Dacomitinib Impurity DF | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C24H26FN5O2. Mole weight: 435.50. | |
| Dacomitinib Impurity DFAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Synonyms: N4-(4-Fluorophenyl)-7-methoxyquinazoline-4,6-diamine (Dacomitinib Impurity); N4-(4-FLUOROPHENYL)-7-METHOXYQUINAZOLINE-4,6-DIAMINE; Dacomitinib Impurity DFAJ; CS-0255390; F83326. Grade: ≥95%. CAS No. 1562180-31-7. Molecular formula: C15H13FN4O. Mole weight: 284.29. | |
| Dacomitinib Impurity DFXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. CAS No. 2185841-22-7. Molecular formula: C15H11FN4O3. Mole weight: 314.27. | |
| Dacomitinib Impurity E | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C24H27ClFN5O3. Mole weight: 487.96. | |
Our database is helping our users find suppliers everyday.
